Cardiac surveillance is mandatory in HER2+ metastatic breast cancer - pro

19 June 2026 (16:30 - 16:40)
Organised by: Logo
Congress Presentation Part of: Rethinking cardiotoxicity monitoring – from tradition to evidence Cardiovascular Toxicity Monitoring Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology